Xalud Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Xalud Therapeutics's estimated annual revenue is currently $8.1M per year.(i)
  • Xalud Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Xalud Therapeutics has 52 Employees.(i)
  • Xalud Therapeutics grew their employee count by 148% last year.

Xalud Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Technical OfficerReveal Email/Phone
3
Chief Development OfficerReveal Email/Phone
4
VP Research And DevelopmentReveal Email/Phone
5
SVP Regulatory Affairs and Quality AssuranceReveal Email/Phone
6
SVP, Global Commercial DevelopmentReveal Email/Phone
7
Chief Medical OfficerReveal Email/Phone
8
Senior Director, Research and DevelopmentReveal Email/Phone
9
Chief Operating OfficerReveal Email/Phone
10
Director Clinical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M40%N/AN/A
#2
$3.7M2441%$44MN/A
#3
$6.2M40-7%N/AN/A
#4
$42M271-1%N/AN/A
#5
$12.7M820%$10MN/A
#6
$2.5M160%N/AN/A
#7
$7.5M450%$51.6MN/A
#8
$0.2M1-50%N/AN/A
#9
$4.3M26-16%$3.3MN/A
#10
$3.7M244%N/AN/A
Add Company

What Is Xalud Therapeutics?

Xalud Therapeutics is a biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation. The company is harnessing the power of interleukin-10 (IL-10), a potent cytokine that acts as a master regulator for multiple inflammatory pathways, to address the root cause of inflammation and subsequently restore homeostasis in the immune system. Xalud's lead product candidate, XT-150, is a locally injectable plasmid DNA gene therapy expressing IL-10 to addresses pathologic inflammation and pain.

keywords:N/A

N/A

Total Funding

52

Number of Employees

$8.1M

Revenue (est)

148%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Xalud Therapeutics News

2022-04-17 - Xalud Therapeutics Adds Amy Chappell, MD, as a Strategic ...

Xalud Therapeutics is a biotechnology company developing a DNA-delivered therapy platform to treat pathologic inflammation through immune...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.4M52-31%N/A
#2
$6.6M5227%N/A
#3
$15M52-9%N/A
#4
$10.3M52-15%N/A
#5
$11.7M52-13%N/A